The National Clinician Consultation Center provides health care providers with a national resource to obtain timely and appropriate responses to clinical questions related to treatment of persons with HIV infection and possible health care worker exposure to HIV and other bloodborne pathogens.
HIV Management Service (Warmline): 800-933-3413
Monday-Friday, 8 a.m. to 8 p.m. Eastern. For questions about HIV/AIDS, including antiretroviral therapy, HIV clinical manifestations, and laboratory evaluation.
electronic Clinician Consultation Service (e-CCS Online Consultation)
For submission of questions about HIV management and case-tracking online. Register at nccc.ucsf.edu.
Post-Exposure Prophylaxis Hotline (PEPline): 888-HIV-4911 (888-448-4911)
For questions about occupational exposures (eg, needlesticks, splashes) to HIV and other bloodborne pathogens. Consultation is available from 9 a.m. to 9 p.m. Eastern, seven days a week.
Perinatal HIV Consultation and Referral Services (Perinatal HIV Hotline): 888-HIV-8765 (888-448-8765)
For questions about the care of HIV-infected pregnant women as well as indications and interpretations of rapid and standard HIV tests.
Pre-Exposure Prophylaxis Service (PrEPline): 855-HIV-PrEP (855-448-7737)
For questions about the appropriateness, administration, and laboratory and follow-up procedures of pre-exposure prophylaxis as a prevention tool.
Clinical Substance Use Consultation (Substance Use Warmline): 855-300-3595
The CCC offers free and confidential peer-to-peer telephone consultation focusing on substance use evaluation and management for primary care clinicians through the Substance Use Warmline at (855) 300-3595. Consultation is available Monday through Friday, between 10 a.m. and 6 p.m Eastern, from addiction medicine-certified physicians, clinical pharmacists, and nurses with expertise in pharmacotherapy options for opioid use. Voicemail is available 24 hours a day.
Hepatitis C Consultation Service (Warmline): 844-437-4636 or 844-(HEP-INFO)
Monday-Friday; 9 a.m. to 5 p.m. Eastern. Call us for clinician-to-clinician advice on hepatitis C monoinfection management, from testing and treatment initiation to management of advanced disease.
In August, the U.S. Public Health Service released updated guidelines for the management of occupational exposures to HIV. In multiple sections of the Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis...
The National Perinatal HIV Clinicians’ Network: Best Practices for Linking HIV-positive Women with Care
Since its inception in 2006, over 330 HIV-positive pregnant women, HIV-exposed infants, and HIV-affected couples seeking safer conception options have been connected with care through the National Perinatal HIV Clinicians’ Network. The Perinatal HIV Clinicians’ Network (part of the National...
PRO Men (Positive Reproductive Outcomes for Men) is an initiative of BAPAC (Bay Area Perinatal AIDS Center) based at San Francisco General Hospital and Trauma Center’s (SFGH) Ward 86 HIV Clinic. PRO Men is aimed at supporting the ~ 500 HIV+ men who have sex with women at Ward 86 HIV Clinic in...
Nearly 1.4% of the country's incarcerated population -- or about 20,500 state prisoners and 1,500 federal prisoners -- is known to be HIV-positive, according to the most currently available data from the U.S. Department of Justice's Bureau of Justice Statistics. Most of this population...
Listening in on the Warmline, PEPline and the Perinatal HIV Hotline: Consultation when Considering PrEP
Pre-exposure prophylaxis (PrEP), specifically the daily use of oral antiretroviral drugs as an HIV prevention measure, has been an increasingly hot topic in the HIV world since studies emerged in 2010 showing promising transmission prevention results among medication-adherent men who have sex...
Taking the Best of the Rapid Testing in Labor and Delivery Project to Fresno, CA: Fresno Perinatal HIV Summit – October 26, 2011
“I learned that HIV patients are the same as other patients with chronic disease and need our attention and care.”
Despite successful uptake of initiatives to increase rapid testing in labor and delivery hospitals throughout California...